Description of the medicine: Logest
Dragees containing 0.075 mg of gestagen gestogen and 0.02 mg of estrogen ethinyl estradiol.
Refers to low-dose (according to the content of ethinyl estradiol) contraceptives.
Method of application, possible complications and contraindications, see "Oral contraceptives" (general part).
Compared with other oral contraceptives, it has the least effect on the metabolism of lipids and carbohydrates, as well as body weight. This is explained by the fact that gestodene, unlike other third-generation progestogen drugs (desogestrel and norgestimate) is characterized by 100% bioavailability and the highest progestogen activity.
Release form: dragees (N. 21).